Balaxi Pharmaceuticals Limited informed the Exchange on 11.11.2025 about the statement of deviation in the utilization of funds raised through a Preferential Issue for the quarter ended September 30, 2025, confirming no deviations or variations in the use of the funds amounting to Rs. 47,56,92,250.